Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from MicroPort NeuroTech Limited ( (HK:2172) ).
MicroPort NeuroScientific Corporation has declared a final ordinary dividend of HKD 0.09 per share for the financial year ended 31 December 2025, with shareholders to approve the payout on 3 June 2026. The dividend will be paid in Hong Kong dollars by default, and shareholders may elect to receive all or part of the dividend in scrip shares instead of cash, with detailed scrip pricing and related arrangements to be announced.
The stock will trade ex-dividend on 2 July 2026, with the record date set for 8 July 2026 and payment scheduled for 21 August 2026, handled by Computershare Hong Kong Investor Services. The cash-and-scrip structure provides existing investors with flexibility to either realise immediate income or reinvest in additional shares, potentially supporting MicroPort NeuroScientific’s capital base while signalling confidence in its earnings for the 2025 financial year.
The most recent analyst rating on (HK:2172) stock is a Buy with a HK$13.00 price target. To see the full list of analyst forecasts on MicroPort NeuroTech Limited stock, see the HK:2172 Stock Forecast page.
More about MicroPort NeuroTech Limited
MicroPort NeuroScientific Corporation is a Hong Kong-listed medical technology company focused on neurointerventional and neuromodulation products. The group develops and markets devices for treating neurological disorders, aiming at both domestic and international healthcare markets through innovation-driven growth and recurring product sales.
Average Trading Volume: 6,697,990
Technical Sentiment Signal: Sell
Current Market Cap: HK$6.2B
See more data about 2172 stock on TipRanks’ Stock Analysis page.